SickKids Peds Nephrology | PhD student | Toronto 🇨🇦 | Aspiring clinician-scientist | Adaptive clinical trials, trial emulation, and health admin data
Joined November 2020
- Tweets 218
- Following 285
- Followers 360
- Likes 1,061
38 Photos and videos
Cal Robinson retweeted
22 Nov 2024
Central venous catheter–related bloodstream infections (CRBSI) are common in children receiving hemodialysis & cause significant morbidity & healthcare costs. Read this Original Article on use of 4% tetrasodium EDTA (KiteLock™) to prevent CRBSI.
link.springer.com/article/10…
6
13
1,412
Cal Robinson retweeted
22 Nov 2024
Steroid-sparing immunosuppression is used in 50% of children w/nephrotic syndrome, but rates & predictors of prolonged remission after cyclophosphamide & tacrolimus are uncertain. Read this Original Article for more.
link.springer.com/article/10…
7
19
1,702
22 Nov 2024
I have made the jump over to BlueSky - follow me there at the same handle @KidneyCal
bsky.app/profile/kidneycal.b…
2
118
Cal Robinson retweeted
16 Nov 2024
AKI affects a growing number of children and neonates and is associated with high morbidity, mortality, and health care expenditure. In this issue of JASN, Robinson et al. present the findings of a large cohort study on the long-term outcomes of AKI in hospitalized children who did not require acute KRT. In this editorial, @KidneyCathy and @emjsee argue that these findings confirm the poor long-term outcomes of AKI in hospitalized children who do not require acute KRT. bit.ly/JASN0508
@MCRI_for_kids
@AU_RMH
1
4
10
1,662
31 Oct 2024
How can simulation be used to improve the design adaptive clinical trials? Read our review article just published in @JASN_News to find out!
Big thanks to co-authors @DrRulanParekh @douyang3 @efan75 @BrianCuthberts8 and Anna Heath.
journals.lww.com/jasn/citati…
5
13
697
Cal Robinson retweeted
25 Oct 2024
Long-Term Kidney Outcomes after Pediatric AKI ca. 2024 from @JASN_News
#Nephpearls #KidneyWk #BestofJASN
#VisualAbstract by @nikkonephro
👉 pubmed.ncbi.nlm.nih.gov/3901…
1
6
9
1,259
25 Oct 2024
Great to see our pediatric AKI long-term outcomes study highlighted in the Best of ASN Journals session at #ASNKids24 #ASN24 @ChanchlaniRahul
4
6
20
1,077
25 Oct 2024
Amazing to see a childhood nephrotic syndrome RCT in the #ASNKids24 @ASNKidney late breaking trials session! So exciting to see RCTs starting to emerge to improve treatment for these children
4
15
866
Cal Robinson retweeted
25 Oct 2024
Excellent poster by Cal Robinson et al on a target trial emulation of cyclophosphamide vs CNIs in #nephroticsyndrome ! #ASNKids24 @ASPNeph @ASNKidney
4
11
660
25 Oct 2024
Come visit our posters today at #ASN2024 #ASNKIDS24 @ASNKidney.
PO-720: Comparative Effectiveness of Cyclophosphamide and Calcineurin Inhibitors in Childhood Nephrotic Syndrome
PO-386: Health Care Resource Utilization and Costs Associated with Childhood Hypertension
1
3
8
532
Cal Robinson retweeted
23 Aug 2024
Using population-based health administrative databases, study investigators found that 1/3 of children with posterior urethral valves develop major adverse kidney events (death, kidney failure, or CKD) by early adulthood, compared with 1% of the general childhood population. bit.ly/JASN0468
ALT Long-Term Kidney Outcomes in Children with Posterior Urethral Valves: A Population-Based Cohort Study
1
11
1,442
Cal Robinson retweeted
23 Aug 2024
Long-Term Kidney Outcomes in Children with Posterior Urethral Valves
#PUV @JASN_News
ow.ly/Pqz450T4EnC
6
11
706
22 Aug 2024
Children with posterior urethral valves are at long-term risk of CKD, kidney failure, and hypertension.
One-third develop major adverse kidney events over median 16.6 year follow-up.
Kidney health surveillance into adulthood with improved transition planning is needed!
21 Aug 2024
I am thrilled to share our newest paper about long term outcomes in #PUV patients using @ICESOntario data, out today in @JASN_News! journals.lww.com/jasn/abstra…
Thanks for the great collaboration @KidneyCal @about__juliane @TimVanMieghem @JoanaRosaP @ChanchlaniRahul @ArmandoJLorenzo
7
29
2,138
Cal Robinson retweeted
2
9
526
Cal Robinson retweeted
7 Aug 2024
Meet IMPaCT Fellow @KidneyCal ! Through his research, Cal aspires to advance the evidence-based treatment of pediatric kidney diseases, prevent adverse long-term outcomes, and minimize disease burden.
Learn more about Cal’s project here:
impactrials.ca/cal-robinson
4
12
516
Cal Robinson retweeted
1 Aug 2024
Interested in learning how to design and operate clinical trials for pregnant people and kids? 🤰👶🧒
Apply for an IMPaCT training award at impactrials.ca/awardinfo!
Applications are open now, so don't miss out – submit by 5 PM CT on October 18, 2024!
1
16
16
4,882
Cal Robinson retweeted
29 Jul 2024
Using population health databases from Ontario, Canada, investigators found that children surviving AKI without acute KRT were at higher long-term risk of CKD, long-term KRT, hypertension, and subsequent AKI compared with hospitalized children without AKI bit.ly/JASN0445
9
18
2,099
Cal Robinson retweeted
25 Jul 2024
Youth diagnosed with hypertension are at higher risk of long-term cardiovascular disease, justifying improving blood pressure follow-up and control strategies among hypertensive youth. #PAS2024 ja.ma/4cFRPls
4
8
1,039